ESTACADA, Ore. — A child from Estacada is progressing well after a new treatment to help with her spinal muscular atrophy. All was going well when Lily Ahrens was born, said her mom, Alysa Ahrens.

The Phase 4 study evaluates clinical outcomes and safety following treatment with SPINRAZA (nusinersen) over two years in infants and toddlers with spinal muscular atrophy (SMA) who have unmet ...

Congenital muscular dystrophy (CMD) is a disease that affects certain muscles. Individuals with CMD may experience symptoms such as muscle weakness and joint problems. “Congenital” means ...

A mother captured the heartwarming moment her toddler, who has a muscle condition, stood by herself unaided. Jessica Quarello documented two-year-old Adeline standing on her own as sister Charlee ...

Biogen has revealed positive interim six-month biomarker data from the Phase IV RESPOND study, focusing on the treatment of infants and toddlers with spinal muscular atrophy (SMA) who still have unmet ...